CapsoVision, Inc

Name: CapsoVision, Inc standardized financial statements, quarterly
Creator: Listed

CVNasdaqCIK 1378325HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$3.6m, Q2 FY2026

Operating income−$7.6m, Q2 FY2026

Net income−$7.5m, Q2 FY2026

CapsoVision, Inc, income statement, quarterly
Line item	Unit	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	period not labelled2024-12-31	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	not reported	2,843	2,966	3,452	2,783	3,315	3,538	3,918	2,792	3,643
Cost of revenue	$k	not reported	1,251	1,309	1,718	1,289	1,504	1,624	1,964	1,463	1,772
Gross profit	$k	not reported	1,592	1,657	1,734	1,494	1,811	1,914	1,954	1,329	1,871
Research and development	$k	not reported	4,222	4,522	3,116	3,107	3,392	6,090	5,721	4,435	5,309
Operating income	$k	not reported	(5,271)	(5,803)	(4,634)	(5,382)	(4,651)	(8,019)	(7,464)	(7,093)	(7,580)
Income tax	$k	not reported	0.0	0.0	11.0	0.0	0.0	0.0	24.0	0.0	0.0
Net income	$k	(4,200)	(5,266)	(5,794)	(4,639)	(5,375)	(4,625)	(7,921)	(7,394)	(7,033)	(7,481)
Diluted EPS	$ per share	not reported	(2.58)	(2.79)	not reported	(2.49)	(2.02)	(0.17)	not reported	(0.15)	(0.15)
Basic EPS	$ per share	not reported	(2.58)	(2.79)	not reported	(2.49)	(2.02)	(0.17)	not reported	(0.15)	(0.15)

Balance sheet

Shareholders' equity$13.2m, Q2 FY2026

CapsoVision, Inc, balance sheet, quarterly
Line item	Unit	period not labelled2023-12-31	period not labelled2024-03-31	period not labelled2024-06-30	period not labelled2024-09-30	period not labelled2024-12-31	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Current assets	$m	not reported	not reported	not reported	not reported	14.8	not reported	7.8	24.0	16.7	24.5	17.3
Total assets	$m	not reported	not reported	not reported	not reported	16.8	not reported	9.5	25.7	18.2	25.9	18.6
Current liabilities	$m	not reported	not reported	not reported	not reported	1.8	not reported	4.2	4.6	4.4	5.4	5.2
Total liabilities	$m	not reported	not reported	not reported	not reported	2.7	not reported	4.9	5.2	4.9	5.7	5.4
Shareholders' equity	$m	(110)	(114)	(119)	(125)	(130)	(135)	(139)	20.4	13.3	20.2	13.2

Cash flow

Operating cash flow−$8.4m, Q2 FY2026

Capital expenditure$0, Q2 FY2026

CapsoVision, Inc, cash flow, quarterly
Line item	Unit	period not labelled2024-09-30	period not labelled2024-12-31	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(7,056)	(5,399)	(4,986)	(4,526)	(5,666)	(7,686)	(6,066)	(8,403)
Capital expenditure	$k	4.0	0.0	40.0	30.0	12.0	8.0	48.0	0.0

Diluted shares (weighted)49.94m, Q2 FY2026

CapsoVision, Inc, shares, quarterly
Line item	Unit	period not labelled2024-06-30	period not labelled2024-09-30	period not labelled2025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	2.0	2.1	2.2	2.3	46.2	47.5	49.9

Shares outstanding: 50.05m at Aug 12, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.